{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:33:00Z","timestamp":1791865980980,"version":"4.3.4"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T00:00:00Z","timestamp":1405987200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s00192-014-2464-0","type":"journal-article","created":{"date-parts":[[2014,7,21]],"date-time":"2014-07-21T15:28:25Z","timestamp":1405956505000},"page":"15-28","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":121,"title":["Assessment of vaginal atrophy: a review"],"prefix":"10.1007","volume":"26","author":[{"given":"M. A.","family":"Weber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Limpens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. P. W. R.","family":"Roovers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,22]]},"reference":[{"issue":"10","key":"2464_CR1","first-page":"3090","volume":"61","author":"GA Bachmann","year":"2000","unstructured":"Bachmann GA, Nevadunsky NS (2000) Diagnosis and treatment of atrophic vaginitis. Am Fam Physician 61(10):3090\u20133096","journal-title":"Am Fam Physician"},{"issue":"4 Pt 1","key":"2464_CR2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/gme.0b013e31815a5168","volume":"15","author":"KB Levine","year":"2008","unstructured":"Levine KB, Williams RE, Hartmann KE (2008) Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women. Menopause 15(4 Pt 1):661\u2013666","journal-title":"Menopause"},{"issue":"3","key":"2464_CR3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.maturitas.2010.08.001","volume":"67","author":"RE Nappi","year":"2010","unstructured":"Nappi RE, Kokot-Kierepa M (2010) Women\u2019s voices in the menopause: results from an international survey on vaginal atrophy. Maturitas 67(3):233\u2013238","journal-title":"Maturitas"},{"issue":"8","key":"2464_CR4","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/j.1743-6109.2009.01335.x","volume":"6","author":"N Santoro","year":"2009","unstructured":"Santoro N, Komi J (2009) Prevalence and impact of vaginal symptoms among postmenopausal women. J Sex Med 6(8):2133\u20132142","journal-title":"J Sex Med"},{"issue":"5","key":"2464_CR5","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1529-8019.2010.01354.x","volume":"23","author":"CS Stika","year":"2010","unstructured":"Stika CS (2010) Atrophic vaginitis. Dermatol Ther 23(5):514\u2013522","journal-title":"Dermatol Ther"},{"key":"2464_CR6","doi-asserted-by":"crossref","unstructured":"Sturdee DW, Panay N, International Menopause Society Writing Group (2010) Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 13(6):509\u2013522","DOI":"10.3109\/13697137.2010.522875"},{"key":"2464_CR7","doi-asserted-by":"crossref","unstructured":"Archer DF (2010) Efficacy and tolerability of local estrogen therapy for urogenital atrophy. Menopause 17(1):194\u2013203","DOI":"10.1097\/gme.0b013e3181a95581"},{"key":"2464_CR8","unstructured":"US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Guidance for Industry (2003) Estrogen and estrogen\/progestin drug products to treat vasomotor symptoms and vulvar and vaginal atrophy symptoms\u2014recommendations for clinical evaluation"},{"key":"2464_CR9","unstructured":"US Department of Health an Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Guidance for Industry (2006) Patient-reported outcome measures: use in medical product development to support labeling claims"},{"issue":"8","key":"2464_CR10","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s11136-009-9528-5","volume":"18","author":"CB Terwee","year":"2009","unstructured":"Terwee CB, Jansma EP, Riphagen II, de Vet HC (2009) Development of a methodological PubMed search filter for finding studies on measurement properties of measurement instruments. Qual Life Res 18(8):1115\u20131123","journal-title":"Qual Life Res"},{"issue":"5","key":"2464_CR11","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1097\/gme.0b013e3181a06c80","volume":"16","author":"JA Chollet","year":"2009","unstructured":"Chollet JA, Carter G, Meyn LA, Mermelstein F, Balk JL (2009) Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis. Menopause 16(5):978\u2013983","journal-title":"Menopause"},{"key":"2464_CR12","doi-asserted-by":"crossref","unstructured":"Castelo-Branco C, Cancelo MJ, Villero J, Nohales F, Juli\u00e1 MD (2005) Management of post-menopausal vaginal atrophy and atrophic vaginitis. Maturitas 52(Suppl 1):S46\u2013S52","DOI":"10.1016\/j.maturitas.2005.06.014"},{"issue":"5 Suppl","key":"2464_CR13","first-page":"6S","volume":"72","author":"PF Brenner","year":"1988","unstructured":"Brenner PF (1988) The menopausal syndrome. Obstet Gynecol 72(5 Suppl):6S\u201311S","journal-title":"Obstet Gynecol"},{"key":"2464_CR14","doi-asserted-by":"crossref","unstructured":"Nyirjesy P, Leigh RD, Mathew L, Lev-Sagie A, Culhane JF (2012) Chronic vulvovaginitis in women older than 50\u00a0years: analysis of a prospective database. J Low Genit Tract Dis 16(1):24\u201329","DOI":"10.1097\/LGT.0b013e31822a198d"},{"issue":"3","key":"2464_CR15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/13697139909038062","volume":"2","author":"GA Greendale","year":"1999","unstructured":"Greendale GA, Zibecchi L, Petersen L, Ouslander JG, Kahn B, Ganz PA (1999) Development and validation of a physical examination scale to assess vaginal atrophy and inflammation. Climacteric 2(3):197\u2013204","journal-title":"Climacteric"},{"issue":"1","key":"2464_CR16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/01.AOG.0000296714.12226.0f","volume":"111","author":"G Bachmann","year":"2008","unstructured":"Bachmann G, Lobo RA, Gut R, Nachtigall L, Notelovitz M (2008) Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Obstet Gynecol 111(1):67\u201376","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2464_CR17","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijgo.2010.12.007","volume":"113","author":"O Karaosmanoglu","year":"2011","unstructured":"Karaosmanoglu O, Cogendez E, Sozen H, Asoglu MR, Akdemir Y, Eren S (2011) Hyaluronic acid in the treatment of postmenopausal women with atrophic vaginitis. Int J Gynaecol Obstet 113(2):156\u2013157","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"2464_CR18","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00042192-200007030-00005","volume":"7","author":"JE Rioux","year":"2000","unstructured":"Rioux JE, Devlin C, Gelfand MM, Steinberg WM, Hepburn DS (2000) 17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis. Menopause 7(3):156\u2013161","journal-title":"Menopause"},{"key":"2464_CR19","doi-asserted-by":"crossref","unstructured":"Lynch C (2009) Vaginal estrogen therapy for the treatment of atrophic vaginitis. J Womens Health (Larchmt) 18(10):1595\u20131606","DOI":"10.1089\/jwh.2008.1281"},{"issue":"11","key":"2464_CR20","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.5858\/arpa.2011-0441-CP","volume":"136","author":"BA Crothers","year":"2012","unstructured":"Crothers BA, Booth CN, Darragh TM, Means MM, Souers RJ, Thomas N, Moriarty AT (2012) Atrophic vaginitis: concordance and interpretation of slides in the College of American Pathologists Cervicovaginal Interlaboratory Comparison Program in Gynecologic Cytopathology. Arch Pathol Lab Med 136(11):1332\u20131338","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"2464_CR21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/ageing\/21.2.117","volume":"21","author":"AE Capewell","year":"1992","unstructured":"Capewell AE, McIntyre MA, Elton RA (1992) Post-menopausal atrophy in elderly women: is a vaginal smear necessary for diagnosis? Age Ageing 21(2):117\u2013120","journal-title":"Age Ageing"},{"issue":"4","key":"2464_CR22","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.maturitas.2004.02.008","volume":"49","author":"B Yildirim","year":"2004","unstructured":"Yildirim B, Kaleli B, D\u00fczcan E, Topuz O (2004) The effects of postmenopausal vitamin D treatment on vaginal atrophy. Maturitas 49(4):334\u2013337","journal-title":"Maturitas"},{"issue":"11","key":"2464_CR23","doi-asserted-by":"crossref","first-page":"e26602","DOI":"10.1371\/journal.pone.0026602","volume":"6","author":"R Hummelen","year":"2011","unstructured":"Hummelen R, Macklaim JM, Bisanz JE, Hammond JA, McMillan A, Vongsa R, Koenig D, Gloor GB, Reid G (2011) Vaginal microbiome and epithelial gene array in post-menopausal women with moderate to severe dryness. PLoS One 6(11):e26602","journal-title":"PLoS One"},{"issue":"2","key":"2464_CR24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.maturitas.2004.04.007","volume":"50","author":"S Palacios","year":"2005","unstructured":"Palacios S, Castelo-Branco C, Cancelo MJ, V\u00e1zquez F (2005) Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy. Maturitas 50(2):98\u2013104","journal-title":"Maturitas"},{"issue":"3","key":"2464_CR25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/gme.0b013e3181c1ac01","volume":"17","author":"GA Bachmann","year":"2010","unstructured":"Bachmann GA, Komi JO, Ospemifene Study Group (2010) Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 study. Menopause 17(3):480\u2013486","journal-title":"Menopause"},{"issue":"3","key":"2464_CR26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0378-5122(95)00955-8","volume":"23","author":"M Bygdeman","year":"1996","unstructured":"Bygdeman M, Swahn ML (1996) Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women. Maturitas 23(3):259\u2013263","journal-title":"Maturitas"},{"issue":"5","key":"2464_CR27","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/gme.0b013e3180399486","volume":"14","author":"J Manonai","year":"2007","unstructured":"Manonai J, Chittacharoen A, Theppisai U, Theppisai H (2007) Effect of Pueraria mirifica on vaginal health. Menopause 14(5):919\u2013924","journal-title":"Menopause"},{"issue":"2","key":"2464_CR28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0020-7292(03)00200-5","volume":"82","author":"V Simuni\u0107","year":"2003","unstructured":"Simuni\u0107 V, Banovi\u0107 I, Ciglar S, Jeren L, Pavici\u0107 Baldani D, Sprem M (2003) Local estrogen treatment in patients with urogenital symptoms. Int J Gynaecol Obstet 82(2):187\u2013197","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"2464_CR29","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/01443610050009692","volume":"20","author":"A Rane","year":"2000","unstructured":"Rane A, Hassan S, Corstiaans A (2000) Does conventional HRT protect from urogenital atrophy? A prospective study. J Obstet Gynaecol 20(3):306\u2013307","journal-title":"J Obstet Gynaecol"},{"issue":"2","key":"2464_CR30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/gme.0b013e3181b7c65f","volume":"17","author":"R Kagan","year":"2010","unstructured":"Kagan R, Williams RS, Pan K, Mirkin S, Pickar JH (2010) A randomized, placebo- and active-controlled trial of bazedoxifene\/conjugated estrogens for treatment of moderate to severe vulvar\/vaginal atrophy in postmenopausal women. Menopause 17(2):281\u2013289","journal-title":"Menopause"},{"key":"2464_CR31","doi-asserted-by":"crossref","unstructured":"Simon J, Nachtigall L, Gut R, Lang E, Archer DF, Utian W (2008) Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet. [Erratum appears in Obstet Gynecol 2008 Dec;112(6):1392]. Obstet Gynecol 112(5):1053\u20131060","DOI":"10.1097\/AOG.0b013e31818aa7c3"},{"key":"2464_CR32","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2147\/PPA.S22940","volume":"5","author":"JA Chollet","year":"2011","unstructured":"Chollet JA (2011) Efficacy and safety of ultra-low-dose Vagifem (10 mcg). Patient Prefer Adherence 5:571\u2013574","journal-title":"Patient Prefer Adherence"},{"issue":"6","key":"2464_CR33","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00404-010-1545-7","volume":"283","author":"M Donne Le","year":"2011","unstructured":"Le Donne M, Caruso C, Mancuso A, Costa G, Iemmo R, Pizzimenti G, Cavallari V (2011) The effect of vaginally administered genistein in comparison with hyaluronic acid on atrophic epithelium in postmenopause. Arch Gynecol Obstet 283(6):1319\u20131323","journal-title":"Arch Gynecol Obstet"},{"key":"2464_CR34","doi-asserted-by":"crossref","unstructured":"Al-Baghdadi O, Ewies AA (2009) Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview. Climacteric 12(2):91\u2013105","DOI":"10.1080\/13697130802585576"},{"key":"2464_CR35","doi-asserted-by":"crossref","unstructured":"Cano A, Est\u00e9vez J, Usandizaga R, Gallo JL, Guinot M, Delgado JL, Castellanos E, Moral E, Nieto C, del Prado JM, Ferrer J (2012) The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005\u00a0% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study. Menopause 19(10):1130\u20131139","DOI":"10.1097\/gme.0b013e3182518e9a"},{"key":"2464_CR36","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/IJWH.S41897","volume":"5","author":"MJ Minkin","year":"2013","unstructured":"Minkin MJ, Maamari R, Reiter S (2013) Improved compliance and patient satisfaction with estradiol vaginal tablets in postmenopausal women previously treated with another local estrogen therapy. Int J Womens Health 5:133\u2013139","journal-title":"Int J Womens Health"},{"key":"2464_CR37","doi-asserted-by":"crossref","unstructured":"Pandit L, Ouslander JG (1997) Postmenopausal vaginal atrophy and atrophic vaginitis. Am J Med Sci 314(4):228\u2013231","DOI":"10.1097\/00000441-199710000-00004"},{"issue":"3","key":"2464_CR38","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/(SICI)1097-0320(19990301)35:3<196::AID-CYTO2>3.0.CO;2-V","volume":"35","author":"JA Laak van der","year":"1999","unstructured":"van der Laak JA, Schijf CP, Kerstens HM, Heijnen-Wijnen TH, de Wilde PC, Hanselaar GJ (1999) Development and validation of a computerized cytomorphometric method to assess the maturation of vaginal epithelial cells. Cytometry 35(3):196\u2013202","journal-title":"Cytometry"},{"key":"2464_CR39","doi-asserted-by":"crossref","unstructured":"McEndree B (1999) Clinical application of the vaginal maturation index. Nurse Pract 24(9):48\u201356","DOI":"10.1097\/00006205-199909000-00004"},{"issue":"4","key":"2464_CR40","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.fertnstert.2007.07.1359","volume":"90","author":"JA Simon","year":"2008","unstructured":"Simon JA, Reape KZ, Wininger S, Hait H (2008) Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women. Fertil Steril 90(4):1132\u20131138","journal-title":"Fertil Steril"},{"issue":"1","key":"2464_CR41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0301-2115(96)02612-7","volume":"71","author":"R Barentsen","year":"1997","unstructured":"Barentsen R, van de Weijer PH, Schram JH (1997) Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy. Eur J Obstet Gynecol Reprod Biol 71(1):73\u201380","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"2464_CR42","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s001920050040","volume":"10","author":"F Casper","year":"1999","unstructured":"Casper F, Petri E (1999) Local treatment of urogenital atrophy with an estradiol-releasing vaginal ring: a comparative and a placebo-controlled multicenter study. Vaginal Ring Study Group. Int Urogynecol J Pelvic Floor Dysfunct 10(3):171\u2013176","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"issue":"1 Pt 1","key":"2464_CR43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0002-9378(96)70378-2","volume":"174","author":"L Henriksson","year":"1996","unstructured":"Henriksson L, Stjernquist M, Boquist L, Cedergren I, Selinus I (1996) A one-year multicenter study of efficacy and safety of a continuous, low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging. Am J Obstet Gynecol 174(1 Pt 1):85\u201392","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"2464_CR44","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0029-7844(03)00764-6","volume":"102","author":"L Speroff","year":"2003","unstructured":"Speroff L (2003) Efficacy and tolerability of a novel estradiol vaginal ring for relief of menopausal symptoms. Obstet Gynecol 102(4):823\u2013834","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2464_CR45","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/0002-9378(94)90074-4","volume":"171","author":"L Henriksson","year":"1994","unstructured":"Henriksson L, Stjernquist M, Boquist L, Alander U, Selinus I (1994) A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy. Am J Obstet Gynecol 171(3):624\u2013632","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"2464_CR46","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1471-0528.1996.tb09741.x","volume":"103","author":"RA Ayton","year":"1996","unstructured":"Ayton RA, Darling GM, Murkies AL, Farrell EA, Weisberg E, Selinus I, Fraser ID (1996) A comparative study of safety and efficacy of continuous low dose oestradiol released from a vaginal ring compared with conjugated equine oestrogen vaginal cream in the treatment of postmenopausal urogenital atrophy. Br J Obstet Gynaecol 103(4):351\u2013358","journal-title":"Br J Obstet Gynaecol"},{"issue":"4","key":"2464_CR47","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/AOG.0b013e3182118790","volume":"117","author":"YK Lee","year":"2011","unstructured":"Lee YK, Chung HH, Kim JW, Park NH, Song YS, Kang SB (2011) Vaginal pH-balanced gel for the control of atrophic vaginitis among breast cancer survivors: a randomized controlled trial. Obstet Gynecol 117(4):922\u2013927","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2464_CR48","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.fertnstert.2006.11.112","volume":"88","author":"HB Zeyneloglu","year":"2007","unstructured":"Zeyneloglu HB, Oktem M, Haberal NA, Esinler I, Kuscu E (2007) The effect of raloxifene in association with vitamin D on vaginal maturation index and urogenital symptoms in postmenopausal osteoporotic women. Fertil Steril 88(2):530\u2013532","journal-title":"Fertil Steril"},{"key":"2464_CR49","doi-asserted-by":"crossref","unstructured":"Speroff L, Haney AF, Gilbert RD, Ellman H, Estradiol Acetate Investigator Group (2006) Efficacy of a new, oral estradiol acetate formulation for relief of menopause symptoms. Menopause 13(3):442\u2013450","DOI":"10.1097\/01.gme.0000182802.06762.b2"},{"issue":"6","key":"2464_CR50","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/01.gme.0000184220.63459.a8","volume":"12","author":"WH Utian","year":"2005","unstructured":"Utian WH, Speroff L, Ellman H, Dart C (2005) Comparative controlled trial of a novel oral estrogen therapy, estradiol acetate, for relief of menopause symptoms. Menopause 12(6):708\u2013715","journal-title":"Menopause"},{"issue":"3","key":"2464_CR51","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00404-010-1382-8","volume":"283","author":"M Ekin","year":"2011","unstructured":"Ekin M, Ya\u015far L, Savan K, Temur M, Uhri M, Gencer I, Kivan\u04ab E (2011) The comparison of hyaluronic acid vaginal tablets with estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Arch Gynecol Obstet 283(3):539\u2013543","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"2464_CR52","first-page":"45","volume":"10","author":"JV Pinkerton","year":"2003","unstructured":"Pinkerton JV, Shifren JL, La Valleur J, Rosen A, Roesinger M, Siddhanti S (2003) Influence of raloxifene on the efficacy of an estradiol-releasing ring for treating vaginal atrophy in postmenopausal women. Menopause 10(1):45\u201352","journal-title":"Menopause"},{"key":"2464_CR53","first-page":"249","volume":"11","author":"A Meisels","year":"1967","unstructured":"Meisels A (1967) The maturation value. Acta Cytol 11:249","journal-title":"Acta Cytol"},{"issue":"3","key":"2464_CR54","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/j.1743-6109.2009.01667.x","volume":"7","author":"C Raghunandan","year":"2010","unstructured":"Raghunandan C, Agrawal S, Dubey P, Choudhury M, Jain A (2010) A comparative study of the effects of local estrogen with or without local testosterone on vulvovaginal and sexual dysfunction in postmenopausal women. J Sex Med 7(3):1284\u20131290","journal-title":"J Sex Med"},{"issue":"4","key":"2464_CR55","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/gme.0b013e318199e734","volume":"16","author":"M Freedman","year":"2009","unstructured":"Freedman M, Kaunitz AM, Reape KZ, Hait H, Shu H (2009) Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy. Menopause 16(4):735\u2013741","journal-title":"Menopause"},{"issue":"2","key":"2464_CR56","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.maturitas.2005.09.011","volume":"54","author":"J Manonai","year":"2006","unstructured":"Manonai J, Songchitsomboon S, Chanda K, Hong JH, Komindr S (2006) The effect of a soy-rich diet on urogenital atrophy: a randomized, cross-over trial. Maturitas 54(2):135\u2013140","journal-title":"Maturitas"},{"key":"2464_CR57","doi-asserted-by":"crossref","unstructured":"Griesser H, Skonietzki S, Fischer T, Fielder K, Suesskind M (2012) Low dose estriol pessaries for the treatment of vaginal atrophy: a double-blind placebo-controlled trial investigating the efficacy of pessaries containing 0.2\u00a0mg and 0.03\u00a0mg estriol. Maturitas 71(4):360\u2013368","DOI":"10.1016\/j.maturitas.2011.12.022"},{"issue":"3","key":"2464_CR58","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/01.AOG.0000254160.62588.41","volume":"109","author":"JA Simon","year":"2007","unstructured":"Simon JA, Bouchard C, Waldbaum A, Utian W, Zborowski J, Snabes MC (2007) Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women: a randomized controlled trial. Obstet Gynecol 109(3):588\u2013596","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2464_CR59","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1067\/mob.2003.23","volume":"188","author":"GW Davila","year":"2003","unstructured":"Davila GW, Singh A, Karapanagiotou I, Woodhouse S, Huber K, Zimberg S, Seiler J, Kopka SL (2003) Are women with urogenital atrophy symptomatic? Am J Obstet Gynecol 188(2):382\u2013388","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"2464_CR60","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/SPV.0b013e31825e6401","volume":"18","author":"DR Karp","year":"2012","unstructured":"Karp DR, Jean-Michel M, Johnston Y, Suciu G, Aguilar VC, Davila GW (2012) A randomized clinical trial of the impact of local estrogen on postoperative tissue quality after vaginal reconstructive surgery. Female Pelvic Med Reconstr Surg 18(4):211\u2013215","journal-title":"Female Pelvic Med Reconstr Surg"},{"issue":"2","key":"2464_CR61","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0378-5122(93)90059-Q","volume":"16","author":"P Smith","year":"1993","unstructured":"Smith P, Heimer G, Lindskog M, Ulmsten U (1993) Oestradiol-releasing vaginal ring for treatment of postmenopausal urogenital atrophy. Maturitas 16(2):145\u2013154","journal-title":"Maturitas"},{"issue":"1","key":"2464_CR62","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0378-5122(94)00863-3","volume":"21","author":"K Nilsson","year":"1995","unstructured":"Nilsson K, Risberg B, Heimer G (1995) The vaginal epithelium in the postmenopause\u2013cytology, histology and pH as methods of assessment. Maturitas 21(1):51\u201356","journal-title":"Maturitas"},{"issue":"1","key":"2464_CR63","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/147323000903700124","volume":"37","author":"AE Yumru","year":"2009","unstructured":"Yumru AE, Bozkurt M, Inci Co\u015fkun E, Baykan G (2009) The use of local 17beta-oestradiol treatment for improving vaginal symptoms associated with post-menopausal oestrogen deficiency. J Int Med Res 37(1):198\u2013204","journal-title":"J Int Med Res"},{"issue":"6","key":"2464_CR64","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/j.1879-3479.1980.tb00204.x","volume":"17","author":"F Benjamin","year":"1980","unstructured":"Benjamin F, Deutsch S (1980) Immunoreactive plasma estrogens and vaginal hormone cytology in postmenopausal women. Int J Gynaecol Obstet 17(6):546\u2013550","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"2464_CR65","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/gme.0b013e3181a48c4e","volume":"16","author":"G Bachmann","year":"2009","unstructured":"Bachmann G, Bouchard C, Hoppe D, Ranganath R, Altomare C, Vieweg A, Graepel J, Helzner E (2009) Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally. Menopause 16(4):719\u2013727","journal-title":"Menopause"},{"key":"2464_CR66","doi-asserted-by":"crossref","unstructured":"Schaffer J, Fantl JA (1996) Urogenital effects of the menopause. Baillieres Clin Obstet Gynaecol 10(3):401\u2013417","DOI":"10.1016\/S0950-3552(96)80022-8"},{"issue":"2","key":"2464_CR67","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00404-011-1955-1","volume":"285","author":"G Capobianco","year":"2012","unstructured":"Capobianco G, Donolo E, Borghero G, Dessole F, Cherchi PL, Dessole S (2012) Effects of intravaginal estriol and pelvic floor rehabilitation on urogenital aging in postmenopausal women. Arch Gynecol Obstet 285(2):397\u2013403","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"2464_CR68","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.GME.0000077620.13164.62","volume":"11","author":"S Dessole","year":"2004","unstructured":"Dessole S, Rubattu G, Ambrosini G, Gallo O, Capobianco G, Cherchi PL, Marci R, Cosmi E (2004) Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women. Menopause 11(1):49\u201356","journal-title":"Menopause"},{"key":"2464_CR69","volume-title":"Menopause: physiology and pharmacology","author":"D Mishell","year":"1987","unstructured":"Mishell D (1987) Menopause: physiology and pharmacology. Yearbook, Chicago"},{"key":"2464_CR70","volume-title":"Textbook of gynaecologic endocrinology","author":"G Wied","year":"1975","unstructured":"Wied G, Bibbo M (1975) Evaluation of endocrinologic condition by exfoliative cytology. In: Gold JJ (ed) Textbook of gynaecologic endocrinology. Harper and Row, New York"},{"issue":"4","key":"2464_CR71","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3109\/00016349309068039","volume":"72","author":"I Milsom","year":"1993","unstructured":"Milsom I, Arvidsson L, Ekelund P, Molander U, Eriksson O (1993) Factors influencing vaginal cytology, pH and bacterial flora in elderly women. Acta Obstet Gynecol Scand 72(4):286\u2013291","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2464_CR72","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/S0002-9378(97)70345-4","volume":"176","author":"J Caillouette","year":"1997","unstructured":"Caillouette J, Sharp C, Zimmerman G, Roy S (1997) Vaginal pH as a marker for bacterial pathogens and menopausal status. Am J Obstet Gynecol 176:1270\u20131275","journal-title":"Am J Obstet Gynecol"},{"key":"2464_CR73","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.ajog.2003.12.015","volume":"190","author":"S Roy","year":"2004","unstructured":"Roy S, Caillouette J, Roy T, Faden J (2004) Vaginal pH is similar to follicle-stimulating hormone for menopause diagnosis. Am J Obstet Gynecol 190:1272\u20131277","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"2464_CR74","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/gme.0b013e31819e8e2d","volume":"16","author":"F Labrie","year":"2009","unstructured":"Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dub\u00e9 R, C\u00f4te I, Labrie C, Lavoie L, Berger L, Gilbert L, Martel C, Balser J (2009) Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy. Menopause 16(5):907\u2013922","journal-title":"Menopause"},{"issue":"5","key":"2464_CR75","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1447-0756.2001.tb01266.x","volume":"27","author":"J Manonai","year":"2001","unstructured":"Manonai J, Theppisai U, Suthutvoravut S, Udomsubpayakul U, Chittacharoen A (2001) The effect of estradiol vaginal tablet and conjugated estrogen cream on urogenital symptoms in postmenopausal women: a comparative study. J Obstet Gynaecol Res 27(5):255\u2013260","journal-title":"J Obstet Gynaecol Res"},{"issue":"5","key":"2464_CR76","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/gme.0b013e3181a15606","volume":"16","author":"GA Bachmann","year":"2009","unstructured":"Bachmann GA, Schaefers M, Uddin A, Utian WH (2009) Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women. Menopause 16(5):877\u2013882","journal-title":"Menopause"},{"key":"2464_CR77","doi-asserted-by":"crossref","unstructured":"Parsons A, Merritt D, Rosen A, Heath H III, Siddhanti S, Plouffe L Jr, Study Groups on the Effects of Raloxifene HCI With Low-Dose Premarin Vaginal Cream (2003) Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in postmenopausal vaginal atrophy. Obstet Gynecol 101(2):346\u2013352","DOI":"10.1016\/S0029-7844(02)02726-6"},{"issue":"6","key":"2464_CR78","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3109\/09513591003632258","volume":"26","author":"N Biglia","year":"2010","unstructured":"Biglia N, Peano E, Sgandurra P, Moggio G, Panuccio E, Migliardi M, Ravarino N, Ponzone R, Sismondi P (2010) Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study. Gynecol Endocrinol 26(6):404\u2013412","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"2464_CR79","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3109\/13697137.2010.535226","volume":"14","author":"F Labrie","year":"2011","unstructured":"Labrie F, Archer DF, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dub\u00e9 R, C\u00f4te I, Labrie C, Lavoie L, Berger L, Gilbert L, Martel C, Balser J (2011) Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareunia. Climacteric 14(2):282\u2013288","journal-title":"Climacteric"},{"key":"2464_CR80","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0029-7844(99)00384-1","volume":"94","author":"S Brizzolara","year":"1999","unstructured":"Brizzolara S, Killeen J, Severino R (1999) Vaginal pH and parabasal cells in postmenopausal women. Obstet Gynecol 94:700\u2013703","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2464_CR81","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/gme.0b013e318182f84b","volume":"15","author":"B Ettinger","year":"2008","unstructured":"Ettinger B, Hait H, Reape KZ, Shu H (2008) Measuring symptom relief in studies of vaginal and vulvar atrophy: the most bothersome symptom approach. Menopause 15(5):885\u2013889","journal-title":"Menopause"},{"issue":"7","key":"2464_CR82","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3109\/09513590903511547","volume":"26","author":"F Labrie","year":"2010","unstructured":"Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dub\u00e9 R, C\u00f4te I, Labrie C, Lavoie L, Berger L, Martel C, Balser J (2010) High internal consistency and efficacy of intravaginal DHEA for vaginal atrophy. Gynecol Endocrinol 26(7):524\u2013532","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"2464_CR83","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S0002-9378(99)70597-1","volume":"180","author":"B Eriksen","year":"1999","unstructured":"Eriksen B (1999) A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol 180(5):1072\u20131079","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2464_CR84","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0028-2243(92)90059-8","volume":"44","author":"PS Eriksen","year":"1992","unstructured":"Eriksen PS, Rasmussen H (1992) Low-dose 17 beta-estradiol vaginal tablets in the treatment of atrophic vaginitis: a double-blind placebo controlled study. Eur J Obstet Gynecol Reprod Biol 44(2):137\u2013144","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"2464_CR85","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/01.gme.0000247016.41007.c9","volume":"13","author":"SG Swanson","year":"2006","unstructured":"Swanson SG, Drosman S, Helmond FA, Stathopoulos VM (2006) Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study. Menopause 13(6):917\u2013925","journal-title":"Menopause"},{"issue":"5","key":"2464_CR86","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1023\/A:1008884703919","volume":"8","author":"SP McKenna","year":"1999","unstructured":"McKenna SP, Whalley D, Renck-Hooper U, Carlin S, Doward LC (1999) The development of a quality of life instrument for use with post-menopausal women with urogenital atrophy in the UK and Sweden. Qual Life Res 8(5):393\u2013398","journal-title":"Qual Life Res"},{"issue":"1","key":"2464_CR87","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/0193945910391483","volume":"34","author":"J Lester","year":"2012","unstructured":"Lester J, Bernhard L, Ryan-Wenger N (2012) A self-report instrument that describes urogenital atrophy symptoms in breast cancer survivors. West J Nurs Res 34(1):72\u201396","journal-title":"West J Nurs Res"},{"issue":"1","key":"2464_CR88","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/13697130500087016","volume":"8","author":"E Weisberg","year":"2005","unstructured":"Weisberg E, Ayton R, Darling G, Farrell E, Murkies A, O\u2019Neill S, Kirkegard Y, Fraser IS (2005) Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet. Climacteric 8(1):83\u201392","journal-title":"Climacteric"},{"key":"2464_CR89","unstructured":"Bachmann G (1994) Vulvo-vaginal complaints. In: Lobo R (ed.) Treatment of the postmenopausal woman. Raven, New York"},{"issue":"3","key":"2464_CR90","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/13697130400003147","volume":"7","author":"N Raymundo","year":"2004","unstructured":"Raymundo N, Yu-cheng B, Zi-yan H, Lai CH, Leung K, Subramaniam R, Bin-rong C, Ling YS, Nasri N, Calimon N (2004) Treatment of atrophic vaginitis with topical conjugated equine estrogens in postmenopausal Asian women. Climacteric 7(3):312\u2013318","journal-title":"Climacteric"},{"issue":"2","key":"2464_CR91","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3109\/01674829709085579","volume":"18","author":"E Laan","year":"1997","unstructured":"Laan E, van Lunsen RH (1997) Hormones and sexuality in postmenopausal women: a psychophysiological study. J Psychosom Obstet Gynaecol 18(2):126\u2013133","journal-title":"J Psychosom Obstet Gynaecol"},{"issue":"16","key":"2464_CR92","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1001\/jama.1983.03330400041022","volume":"249","author":"S Leiblum","year":"1983","unstructured":"Leiblum S, Bachmann G, Kemmann E, Colburn D, Swartzman L (1983) Vaginal atrophy in the postmenopausal woman. The importance of sexual activity and hormones. JAMA 249(16):2195\u20132198","journal-title":"JAMA"},{"issue":"1","key":"2464_CR93","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/13697137.2011.647840","volume":"15","author":"RE Nappi","year":"2012","unstructured":"Nappi RE, Kokot-Kierepa M (2012) Vaginal health: insights, views & attitudes (VIVA) - results from an international survey. Climacteric 15(1):36\u201344","journal-title":"Climacteric"},{"issue":"1","key":"2464_CR94","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/PL00004023","volume":"11","author":"JM Geelen van","year":"2000","unstructured":"van Geelen JM, van de Weijer PH, Arnolds HT (2000) Urogenital symptoms and resulting discomfort in non-institutionalized Dutch women aged 50-75 years. Int Urogynecol J Pelvic Floor Dysfunct 11(1):9\u201314","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"issue":"4","key":"2464_CR95","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.maturitas.2004.06.019","volume":"49","author":"LM Pastore","year":"2004","unstructured":"Pastore LM, Carter RA, Hulka BS, Wells E (2004) Self-reported urogenital symptoms in postmenopausal women: Women\u2019s Health Initiative. Maturitas 49(4):292\u2013303","journal-title":"Maturitas"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-014-2464-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00192-014-2464-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-014-2464-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T20:32:16Z","timestamp":1649709136000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00192-014-2464-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,22]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["2464"],"URL":"https:\/\/doi.org\/10.1007\/s00192-014-2464-0","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,22]]}}}